BioLineRx Ltd.
USPTO PatentsView assignee record - 17 granted patents across 3 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Biolinerx ranks #16,634 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 3 technology areas.
- #16,634
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (41.2/100)
- 8.5
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R16634 · Foreign Corporation #16,634 · 17 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 17 grants
- MID-PACK #16,634/49,997
- PHOTO-FINISH Beijing Rockrobo…
- CPC-NARROW C07K · 3 areas
- INNOV-PAR 41.2/100
- CLAIMS-PAR 8.5 claims/avg
- TYPE-FRNCORP Foreign Corp
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Beijing Rockrobo Technology Co., Ltd. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Biolinerx’s 41.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Biolinerx
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- BioLineRx · this assignee
BioLineRx · this assignee
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Biolinerx's Innovation Score is 41.2/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Biolinerx?
Each dot is one of Biolinerx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biolinerx’s own 8.5 claims/patent is at or below the 12.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Biolinerx's grants concentrate
BioLineRx Ltd. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2023 (10 grants) versus a trough of 1 in 2022. By volume, Biolinerx sits between BYK-Gardner GmbH and Biora Therapeutics, Inc..
Biolinerx's three-year grant acceleration
BioLineRx Ltd. shows 12 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at BioLineRx's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Byk-gardner
BYK-Gardner GmbH
17 patents
- Beijing Rockrobo…
Beijing Rockrobo Technology Co., Ltd.
17 patents
- Benshot
BenShot, LLC
17 patents
- Beyondspring Pham…
BeyondSpring Phamaceuticals, Inc.
17 patents
- Bioxcel Therapeut…
BioXcel Therapeutics, Inc.
17 patents
- Bioaxial SAS
Bioaxial SAS
17 patents
- Biological Innova…
Biological Innovation and Optimization Systems, LLC
17 patents
- Biora Therapeutics
Biora Therapeutics, Inc.
17 patents
- Biolinerx ◀
BioLineRx Ltd.
17 patents
What this shows BioLineRx holds 17 patents at rank #16,647, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near BioLineRx
By rank, the assignees closest to #16,647 in granted patent volume.
- BYK-Gardner GmbH #16,643 · 17 patents
- Beijing Rockrobo Technology Co., Ltd. #16,644 · 17 patents
- BenShot, LLC #16,645 · 17 patents
- BeyondSpring Phamaceuticals, Inc. #16,646 · 17 patents
- BioXcel Therapeutics, Inc. #16,648 · 17 patents
- Bioaxial SAS #16,649 · 17 patents
- Biological Innovation and Optimization Systems, LLC #16,650 · 17 patents
- Biora Therapeutics, Inc. #16,651 · 17 patents
Leaders in C07K (Peptides)
Other assignees with the most granted patents in BioLineRx's primary technology class.
- The Regents of the University of California 894 in class
- Regeneron Pharmaceuticals, Inc. 824 in class
- Immatics Biotechnologies GmbH 678 in class
- Genentech, Inc. 565 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 513 in class
- The Trustees of the University of Pennsylvania 501 in class
- Novartis AG 407 in class
- The Board of Trustees of the Leland Stanford Junior University 400 in class
Biolinerx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 11.8% |
| 2022 | 1 | 5.9% |
| 2023 | 10 | 58.8% |
| 2024 | 1 | 5.9% |
| 2025partial year | 3 | 17.6% |
Which technologies does BioLineRx Ltd. patent most?
Top 3 of 3 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
BioLineRx Ltd.'s patent record in context - here's where to go next.
- BioLineRx Ltd.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
- Ranked #16,634 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare BioLineRx Ltd. against BYK-Gardner GmbH, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 41.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.